Mukta Srivastava, MD, assistant professor of medicine and structural heart specialist, discusses basic principles and best practices associated with the rigorously studied left atrial appendage (LAA) occlusion device, Watchman. The optimal population to benefit from device implantation remains to be fully defined, but in the right patient with bleeding risk and significant stroke risk, the Watchman is a great option to offer patients who are often otherwise undertreated for their atrial fibrillation related stroke risk.